St Louis Trust’s Allergan plc AGN Stock Holding History

St Louis Trust’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-938	Closed	-$251K	–	62
2016 Q1	$251K	Buy	+938	New	+$269K	0.14%	56

Other funds holding AGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

St Louis Trust's AGN Position: Q2 2016 in Review

St Louis Trust sold out of Allergan plc (AGN) in Q2 2016, closing a stake of 938 shares — an estimated $251K sold.

St Louis Trust first reported a position in AGN in Q1 2016 and held it in 1 quarter. The position peaked at $251K in Q1 2016. 1,107 funds tracked by Wall St. Rank hold AGN as of Q2 2016.

St Louis Trust reported no remaining Allergan plc position as of Q2 2016 after selling out during the quarter.
St Louis Trust sold 938 Allergan plc shares in Q2 2016, an estimated $251K.
St Louis Trust first reported a position in Allergan plc in Q1 2016 and held it in 1 quarter.
St Louis Trust's Allergan plc position peaked at $251K in Q1 2016.
1,107 funds tracked by Wall St. Rank held Allergan plc as of Q2 2016.

Based on St Louis Trust's 13F filing for Q2 2016, filed 5 Aug 2016.